CO4950614A1 - Antagonistas de taquiquinina - Google Patents
Antagonistas de taquiquininaInfo
- Publication number
- CO4950614A1 CO4950614A1 CO98001002A CO98001002A CO4950614A1 CO 4950614 A1 CO4950614 A1 CO 4950614A1 CO 98001002 A CO98001002 A CO 98001002A CO 98001002 A CO98001002 A CO 98001002A CO 4950614 A1 CO4950614 A1 CO 4950614A1
- Authority
- CO
- Colombia
- Prior art keywords
- compound
- formula
- production
- acid addition
- addition salt
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 8
- 239000002253 acid Chemical group 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 150000001350 alkyl halides Chemical class 0.000 abstract 1
- -1 chlorine Chemical class 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700597.9A GB9700597D0 (en) | 1997-01-14 | 1997-01-14 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4950614A1 true CO4950614A1 (es) | 2000-09-01 |
Family
ID=10805904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98001002A CO4950614A1 (es) | 1997-01-14 | 1998-01-13 | Antagonistas de taquiquinina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6107293A (enExample) |
| EP (1) | EP0964867B1 (enExample) |
| JP (2) | JP4306804B2 (enExample) |
| AR (1) | AR011521A1 (enExample) |
| AT (1) | ATE290546T1 (enExample) |
| AU (1) | AU5764298A (enExample) |
| CA (1) | CA2278057C (enExample) |
| CO (1) | CO4950614A1 (enExample) |
| DE (1) | DE69732715T2 (enExample) |
| ES (1) | ES2239368T3 (enExample) |
| GB (1) | GB9700597D0 (enExample) |
| PT (1) | PT964867E (enExample) |
| WO (1) | WO1998031704A2 (enExample) |
| ZA (1) | ZA98256B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426331B1 (en) | 1998-07-08 | 2002-07-30 | Tularik Inc. | Inhibitors of STAT function |
| GB9815696D0 (en) * | 1998-07-20 | 1998-09-16 | Pfizer Ltd | Heterocyclics |
| CA2362290A1 (en) | 1999-02-18 | 2000-08-24 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| AU2000249828A1 (en) * | 2000-05-03 | 2001-11-12 | Taisho Pharmaceutical Co. Ltd. | Stat4 and stat6 binding dipeptide derivatives |
| US6884782B2 (en) | 2000-11-08 | 2005-04-26 | Amgen Inc. | STAT modulators |
| US20070219214A1 (en) * | 2006-02-01 | 2007-09-20 | Solvay Pharmaceuticals Gmbh | Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| KR20090071581A (ko) | 2006-10-16 | 2009-07-01 | 라이온 가부시키가이샤 | Ｎｋ１ 수용체 앤태고니스트 조성물 |
| WO2013004766A1 (en) | 2011-07-04 | 2013-01-10 | Ferrari Giulio | Nk-1 receptor antagonists for treating corneal neovascularisation |
| CA3091944A1 (en) | 2018-02-26 | 2019-08-29 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
| WO2021180885A1 (en) | 2020-03-11 | 2021-09-16 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ210669A (en) * | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| GB8929070D0 (en) * | 1989-12-22 | 1990-02-28 | Fujisawa Pharmaceutical Co | Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same |
| FR2719312B1 (fr) * | 1994-04-28 | 1996-06-14 | Adir | Nouveau pseudopeptides dérivés de neurokinines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-01-14 GB GBGB9700597.9A patent/GB9700597D0/en active Pending
- 1997-12-29 US US09/341,626 patent/US6107293A/en not_active Expired - Lifetime
- 1997-12-29 EP EP97953927A patent/EP0964867B1/en not_active Expired - Lifetime
- 1997-12-29 CA CA002278057A patent/CA2278057C/en not_active Expired - Fee Related
- 1997-12-29 WO PCT/EP1997/007307 patent/WO1998031704A2/en not_active Ceased
- 1997-12-29 AU AU57642/98A patent/AU5764298A/en not_active Abandoned
- 1997-12-29 AT AT97953927T patent/ATE290546T1/de not_active IP Right Cessation
- 1997-12-29 PT PT97953927T patent/PT964867E/pt unknown
- 1997-12-29 ES ES97953927T patent/ES2239368T3/es not_active Expired - Lifetime
- 1997-12-29 DE DE69732715T patent/DE69732715T2/de not_active Expired - Lifetime
- 1997-12-29 JP JP53360998A patent/JP4306804B2/ja not_active Expired - Fee Related
-
1998
- 1998-01-09 AR ARP980100097A patent/AR011521A1/es active IP Right Grant
- 1998-01-13 CO CO98001002A patent/CO4950614A1/es unknown
- 1998-01-13 ZA ZA98256A patent/ZA98256B/xx unknown
-
2005
- 2005-11-29 JP JP2005344056A patent/JP3817256B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4306804B2 (ja) | 2009-08-05 |
| ES2239368T3 (es) | 2005-09-16 |
| GB9700597D0 (en) | 1997-03-05 |
| ATE290546T1 (de) | 2005-03-15 |
| PT964867E (pt) | 2005-07-29 |
| CA2278057C (en) | 2004-05-04 |
| DE69732715D1 (de) | 2005-04-14 |
| US6107293A (en) | 2000-08-22 |
| JP3817256B2 (ja) | 2006-09-06 |
| ZA98256B (en) | 1998-07-14 |
| CA2278057A1 (en) | 1998-07-23 |
| AR011521A1 (es) | 2000-08-30 |
| JP2000516257A (ja) | 2000-12-05 |
| EP0964867B1 (en) | 2005-03-09 |
| WO1998031704A2 (en) | 1998-07-23 |
| WO1998031704A3 (en) | 1998-09-11 |
| EP0964867A2 (en) | 1999-12-22 |
| JP2006089499A (ja) | 2006-04-06 |
| DE69732715T2 (de) | 2006-04-13 |
| AU5764298A (en) | 1998-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR246433A1 (es) | Un procedimiento para desinfectar un substrato. | |
| ES2059395T3 (es) | Composiciones blanqueadoras, peracidos de esteres glicolicos y precursores. | |
| ES2051719T3 (es) | Un procedimiento para producir un compuesto de benzoilurea. | |
| PE1998A1 (es) | DERIVADOS DE BENZO [g] QUINOLINA | |
| FR2512024B1 (enExample) | ||
| ES8506677A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina. | |
| CO4950614A1 (es) | Antagonistas de taquiquinina | |
| AR248018A1 (es) | Procedimiento para preparar compuestos de (1h)-bencimidazol-2-il-piperidinilmetanona. | |
| ES2093672T3 (es) | Composicion blanqueante liquida acuosa. | |
| AR245933A1 (es) | Procedimiento para preparar compuestos de 4-(3-hidroxifenil)metil-3-alquil-n-alquilpiperidina y sus sales. | |
| ATE468109T1 (de) | Liposomale abgabe von verbindungen auf vitamin-e- basis | |
| ES2051843T3 (es) | Un proceso para la preparacion de un derivado del acido benzoilaminofenoxibutanico. | |
| ES2062486T3 (es) | 3-fenilbenzofuran-2-onas. | |
| ES8401026A1 (es) | Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos. | |
| NO20025054L (no) | Oksidasjonsprosess for fremstilling av mellomproduktet 6.alfa., 9.alfa.-difluor-11.beta., 17.alfa.-dihydroksy-16.alfa.-metyl-androst-1,4-dien-3-on 17.beta.-karboksylsyre | |
| ES8705408A1 (es) | Un procedimiento para preparar un derivado de 1,5-benzotiazepina. | |
| PE22491A1 (es) | Compuesto de imidazol y composiciones para el tratamiento de textiles que lo contienen | |
| CO4980887A1 (es) | Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico | |
| ES8202001A1 (es) | Procedimiento de producir dihidropiridinas n-morfolinoalqui-licas | |
| ES2080726T3 (es) | Compuestos aromaticos o heteroaromaticos nitrosustituidos para su utilizacion en el tratamiento del cancer. | |
| ES2098219T3 (es) | Compuestos de purina y su preparacion. | |
| ES2189184T3 (es) | Mezclas fungicidas. | |
| ES8507527A1 (es) | Procedimiento para producir derivados de tiatriazina | |
| DE69815380D1 (de) | N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind | |
| KR840006238A (ko) | 신규 α-아릴-α-피리딜알카노인산 유도체의 제조방법 |